Werntz Ryan P, Martinez-Acevedo Ann, Amadi Hamed, Kopp Ryan, La Rochelle Jeffrey, Koppie Theresa, Amling Christopher, Sajadi Kamran P
Department of Urology, Oregon Health and Science University, Portland, OR.
Department of Urology, Oregon Health and Science University, Portland, OR.
Urol Oncol. 2018 May;36(5):238.e1-238.e5. doi: 10.1016/j.urolonc.2017.12.025. Epub 2018 Jan 12.
Urinary tract infections (UTI) and sepsis contribute significantly to the morbidity associated with cystectomy and urinary diversion in the first 30 days. We hypothesized that continuous antibiotic prophylaxis decreased UTIs in the first 30 days following radical cystectomy.
Patients with urothelial carcinoma of the bladder who underwent a radical cystectomy with urinary diversion for bladder cancer at Oregon Health and Science University from January 2014 to May 2015 were included in the study. The ureteral stents were kept for 3 weeks in both groups. In October 2014, we enacted a Department Quality Initiative to reduce UTIs. Following the initiative, all radical cystectomy patients were discharged home on antibiotic prophylaxis following a postoperative urine culture obtained during hospitalization. To evaluate the effectiveness of the initiative, the last 42 patients before the initiative were compared to the first 42 patients after the initiative with regard to the rate of UTI in the first 30 days following surgery. We used a combination of comprehensive chart review and the American College of Surgeons' National Surgical Quality Improvement Program (NSQIP) to determine UTI and readmission for urosepsis in the first 30 days following surgery. This ensured accurate capture of all patients developing a UTI.
A total of 12% in the prophylactic antibiotic group had a documented UTI, whereas 36% in the no antibiotic group had a urinary tract infection (P<0.004). A total of 1 (2%) patient in the antibiotic group was readmitted for urosepsis whereas 7 (17%) patients in the no antibiotic group were admitted for urosepsis (P = 0.02). There was no association noted between urine culture at discharge and the development of UTI in the 30-day postdischarge period (P = 0.75). The median time to UTI was 19 days and the most common organism was Enterococcus (32%). Thirty-percent of patients not receiving prophylaxis developed a UTI 1 day after ureteral stent removal. No patients had a UTI following stent removal in the prophylaxis group. No adverse antibiotic related events were noted.
Prophylactic antibiotics in the 30 days following radical cystectomy is associated with a significant decrease in urinary tract infections and readmission from urosepsis after surgery.
尿路感染(UTI)和脓毒症是膀胱全切术及尿路改道术后30天内发病的重要原因。我们假设,持续预防性使用抗生素可降低根治性膀胱切除术后30天内的UTI发生率。
纳入2014年1月至2015年5月在俄勒冈健康与科学大学因膀胱癌接受根治性膀胱切除术并尿路改道的膀胱尿路上皮癌患者。两组患者输尿管支架均留置3周。2014年10月,我们发起了一项科室质量改进计划以减少UTI。计划实施后,所有根治性膀胱切除患者在住院期间进行术后尿培养后,出院时均接受抗生素预防性治疗。为评估该计划的效果,将计划实施前的最后42例患者与计划实施后的前42例患者在术后30天内的UTI发生率进行比较。我们采用综合病历审查和美国外科医师学会国家外科质量改进计划(NSQIP)相结合的方法来确定术后30天内的UTI及因尿脓毒症再次入院的情况。这确保了准确记录所有发生UTI的患者。
预防性使用抗生素组中有12%的患者有UTI记录,而未使用抗生素组中有36%的患者发生尿路感染(P<0.004)。抗生素组中有1例(2%)患者因尿脓毒症再次入院,而未使用抗生素组中有7例(17%)患者因尿脓毒症入院(P = 0.02)。出院时的尿培养结果与出院后30天内UTI的发生之间未发现关联(P = 0.75)。UTI的中位发生时间为19天,最常见的病原体是肠球菌(32%)。30%未接受预防性治疗的患者在输尿管支架取出后1天发生UTI。预防性治疗组中无患者在支架取出后发生UTI。未观察到与抗生素相关的不良事件。
根治性膀胱切除术后30天内预防性使用抗生素与术后尿路感染及因尿脓毒症再次入院的显著减少相关。